Jun. 18, 2022

RLX-33

intraperitoneal Relaxin-3/RXFP3 antagonist in vivo efficacy in induced food intake rats models from 19000 compound HTS and opt. J. Med. Chem., May 20, 2022 Research Triangle Institute, Durham, NC

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in